Work

The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties

Year: 2010

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.110.174011

Authors: Barbara J. Caldarone, Neil E. Paterson, Jia Zhou, Daniela Brunner, Alan P. Kozikowski, Koen G.C. Westphal, Gerdien A.H. Korte-Bouws, Jolanda Prins, S. Mechiel Korte, Berend Olivier, Afshin Ghavami

Institutions: Psychogenics (United States), New York State Psychiatric Institute, Columbia University, University of Illinois Chicago, Utrecht University

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Mental Health

Awards: G5210801744, Piperidine-Based Compounds as Therapeutics for Narcolepsy-Cataplexy

OpenAlex ID: W2102016076

FWCI: 2.599

Cites: 42

Cited by: 26

Related to: 10